Adaptive Biotechnologies Corporation - SIC # -

Ticker Exchange SIC # Website Latest Ticker
ADPT Nasdaq www.adaptivebiotech.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adaptive Biotechnologies Corporation

Adaptive unveils data of MRD assessment test in blood cancer treatment - Dec 9th, 2024 2:53 pm
Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions - Dec 7th, 2024 11:30 pm
Adaptive Research and WRO to expand cancer trial access in San Francisco Bay Area - Dec 5th, 2024 12:16 pm
Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting - Dec 3rd, 2024 12:30 pm
Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year? - Nov 29th, 2024 2:40 pm
Novotech report notes shift to adaptive designs in clinical trials - Nov 25th, 2024 6:55 pm
Wall Street Analysts Predict a 31.36% Upside in Adaptive Biotechnologies (ADPT): Here's What You Should Know - Nov 15th, 2024 2:55 pm
Is Cardinal Health (CAH) Outperforming Other Medical Stocks This Year? - Nov 13th, 2024 2:40 pm
Adaptive Biotechnologies Third Quarter 2024 Earnings: Beats Expectations - Nov 9th, 2024 1:52 pm
Q3 2024 Adaptive Biotechnologies Corp Earnings Call - Nov 8th, 2024 3:18 pm
Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ... - Nov 8th, 2024 7:29 am
Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Nov 7th, 2024 11:30 pm
Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue Estimates - Nov 7th, 2024 11:15 pm
Adaptive Biotechnologies: Q3 Earnings Snapshot - Nov 7th, 2024 10:11 pm
Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results - Nov 7th, 2024 9:05 pm
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma - Nov 7th, 2024 12:30 pm
November 2024's Top US Penny Stocks With Growth Potential - Nov 1st, 2024 1:09 pm
Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024 - Oct 9th, 2024 8:05 pm
Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year? - Oct 7th, 2024 1:40 pm
Parametric company Adaptive Insurance launches operations - Oct 4th, 2024 8:35 am